Target Biotech Firms Position ProteinMentor as a ready-to-deploy high-throughput platform for pre-clinical candidate selection and comparability assessments to small-to-mid biotech and early-stage biopharma companies focusing on biologics.

Quality and Compliance Emphasize ICH Q5E alignment, robust statistically driven results, and 21 CFR Part 11 compliant data management to address regulators and quality teams seeking reliable process control change assessments and batch-to-batch evaluations.

Speed to Market Highlight the platform’s ability to accelerate development timelines and decision making for clinical candidates, offering a competitive edge for sponsors aiming to shorten time to regulatory filing and market entry.

High-Value Use Cases Leverage capabilities in multi-attribute evaluation of CQAs such as aggregation, glycosylation, deamidation, and epitope mapping to target teams responsible for developability screening, formulation optimization, and stability studies.

Strategic Partnerships Leverage recent funding and awards history, plus a cloud-ready, scalable platform, to pursue collaborations with CROs, pharma sponsors, and academic institutions seeking advanced analytical tools and data management for biologics developability and comparability projects.